SUMMIT X, LLC – Lineage Cell Therapeutics, Inc. Transaction History
SUMMIT X, LLC portfolio value:
$29,000
portfolio value
SUMMIT X, LLC quarter portfolio value change:
-28.48%
quarter
Lineage Cell Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -16.71% | -5K shares | -19K | $1.13 | 24.92K |
| Q2 2022 | share | Decrease | -3.23% | -1K shares | 0 | $1.58 | 29.92K |
| Q1 2022 | share | Decrease | -3.13% | -1K shares | -30K | $1.54 | 30.92K |
| Q4 2021 | share | Increase | +10.37% | 3K shares | 6K | $2.5 | 31.92K |
| Q3 2021 | share | Decrease | -0.26% | -75 shares | -10K | $2.52 | 28.92K |
| Q2 2021 | share | Decrease | -9.38% | -3K shares | 7K | $2.85 | 29K |
| Q1 2021 | share | Increase | +3.23% | 1K shares | 20K | $2.35 | 32K |
| Q4 2020 | share | Increase | +6.90% | 2K shares | 54.99K | $1.76 | 31K |
| Q3 2020 | share | 0.00% | 0 shares | -24.99K | $0.94 | 29K | |
| Q2 2020 | share | Decrease | -5.54% | -1.7K shares | 0 | $0.87 | 29K |
| Q1 2020 | share | Increase | +44.81% | 9.5K shares | 6K | $0.83 | 30.7K |
| Q4 2019 | share | Increase | +16.48% | 3K shares | 1K | $0.89 | 21.2K |
| Q3 2019 | share | Increase | 0.00% | 18.2K shares | 18K | $0.98 | 18.2K |